In our investigation, we observed altered immune–inflammatory parameters in BC patients, characterised by an increased ratio of TREM-1 to TREM-2 (%, MFI) expressions on CD14+ monocytes, compared to healthy control subjects. The gene discussed is TREM2; the disease is breast cancer.